DD210046A5 - Verfahren zur herstellung von indolizinderivaten - Google Patents

Verfahren zur herstellung von indolizinderivaten Download PDF

Info

Publication number
DD210046A5
DD210046A5 DD83252093A DD25209383A DD210046A5 DD 210046 A5 DD210046 A5 DD 210046A5 DD 83252093 A DD83252093 A DD 83252093A DD 25209383 A DD25209383 A DD 25209383A DD 210046 A5 DD210046 A5 DD 210046A5
Authority
DD
German Democratic Republic
Prior art keywords
derivatives
methanol
indolizine
pharmaceutically acceptable
oxalate
Prior art date
Application number
DD83252093A
Other languages
German (de)
English (en)
Inventor
Gilbert Rosseels
Peter Polster
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DD210046A5 publication Critical patent/DD210046A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Telephonic Communication Services (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • External Artificial Organs (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DD83252093A 1982-06-17 1983-06-16 Verfahren zur herstellung von indolizinderivaten DD210046A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8210598A FR2528845A1 (fr) 1982-06-17 1982-06-17 Nouveaux derives d'indolizine, leur procede de preparation ainsi que les compositions therapeutiques les contenant

Publications (1)

Publication Number Publication Date
DD210046A5 true DD210046A5 (de) 1984-05-30

Family

ID=9275110

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83252093A DD210046A5 (de) 1982-06-17 1983-06-16 Verfahren zur herstellung von indolizinderivaten

Country Status (25)

Country Link
US (1) US4499095A (xx)
EP (1) EP0097636B1 (xx)
JP (1) JPS5980682A (xx)
KR (1) KR870001065B1 (xx)
AT (1) ATE15042T1 (xx)
AU (1) AU553758B2 (xx)
BE (1) BE897059A (xx)
CA (1) CA1195979A (xx)
CS (1) CS240963B2 (xx)
DD (1) DD210046A5 (xx)
DE (1) DE3360609D1 (xx)
DK (1) DK158000C (xx)
ES (1) ES523389A0 (xx)
FI (1) FI74000C (xx)
FR (1) FR2528845A1 (xx)
GR (1) GR78285B (xx)
HU (1) HU189298B (xx)
IE (1) IE55429B1 (xx)
IL (1) IL68778A (xx)
NO (1) NO159723C (xx)
NZ (1) NZ204608A (xx)
PT (1) PT76876B (xx)
SU (1) SU1194272A3 (xx)
YU (1) YU43313B (xx)
ZA (1) ZA833875B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215988A (en) * 1986-02-14 1993-06-01 Sanofi Aminoalkoxyphenyl derivatives, process of preparation and compositions containing the same
FR2642755B1 (xx) * 1989-02-07 1993-11-05 Sanofi
FR2642756B1 (fr) * 1989-02-07 1994-03-04 Sanofi Derives cycloaminoalkoxyphenyle, leur procede de preparation ainsi que les compositions pharmaceutiques ou veterinaires en contenant
AU668691B2 (en) * 1991-08-09 1996-05-16 Nycomed Innovation Ab Use of persistent free-radicals in magnetic resonance imaging
FR2838123B1 (fr) * 2002-04-04 2005-06-10 Sanofi Synthelabo Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
FR2859997B1 (fr) * 2003-09-18 2006-02-03 Sanofi Synthelabo Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI61030C (fi) * 1976-02-19 1982-05-10 Sanofi Sa Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat
US4378362A (en) * 1979-12-06 1983-03-29 S.A. Labaz N.V. Indolizine derivatives and process for preparing the same
FR2495616A1 (fr) * 1980-12-09 1982-06-11 Labaz Nv Nouveaux derives d'indolizine, leur procede de preparation ainsi que leurs applications en therapeutique

Also Published As

Publication number Publication date
YU43313B (en) 1989-06-30
IL68778A0 (en) 1983-09-30
JPS5980682A (ja) 1984-05-10
IE55429B1 (en) 1990-09-12
FI74000B (fi) 1987-08-31
IL68778A (en) 1986-10-31
IE831408L (en) 1983-12-17
ES8403900A1 (es) 1984-04-01
DK158000B (da) 1990-03-12
PT76876A (en) 1983-07-01
FI832209L (fi) 1983-12-18
FR2528845A1 (fr) 1983-12-23
EP0097636B1 (fr) 1985-08-21
NO832176L (no) 1983-12-19
CS440183A2 (en) 1985-06-13
KR840005140A (ko) 1984-11-03
US4499095A (en) 1985-02-12
DK158000C (da) 1990-08-20
DK276183D0 (da) 1983-06-15
NZ204608A (en) 1985-09-13
JPH0372072B2 (xx) 1991-11-15
NO159723B (no) 1988-10-24
HU189298B (en) 1986-06-30
AU553758B2 (en) 1986-07-24
ATE15042T1 (de) 1985-09-15
ES523389A0 (es) 1984-04-01
SU1194272A3 (ru) 1985-11-23
ZA833875B (en) 1984-02-29
NO159723C (no) 1989-02-01
CS240963B2 (en) 1986-03-13
FI832209A0 (fi) 1983-06-16
DK276183A (da) 1983-12-18
GR78285B (xx) 1984-09-26
EP0097636A1 (fr) 1984-01-04
YU133183A (en) 1986-02-28
FR2528845B1 (xx) 1984-11-23
PT76876B (en) 1986-01-27
DE3360609D1 (en) 1985-09-26
CA1195979A (en) 1985-10-29
KR870001065B1 (ko) 1987-05-27
BE897059A (fr) 1983-12-16
FI74000C (fi) 1987-12-10
AU1542483A (en) 1984-12-20

Similar Documents

Publication Publication Date Title
DD205904A5 (de) Verfahren zur herstellung von imidazo (4,5-c) pyridin-derivaten
DE2934747A1 (de) Tetrazolylalkoxycarbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
DE2933649A1 (de) Imidazolderivate, sie enthaltende pharmazeutische zusammensetzungen
US3949089A (en) Substituted guanidine compounds as antifibrillatory agents
DE2027645A1 (de) Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
DD159071A5 (de) Verfahren zur darstellung von pyridoxinderivaten und ihre verwendung in therapeutica
DE2707048A1 (de) Neue indolizinderivate, verfahren zu deren herstellung, sowie diese enthaltende zusammensetzungen
EP1071671A2 (de) Triazolone mit neuroprotektiver wirkung
DE3248957C2 (xx)
DD210046A5 (de) Verfahren zur herstellung von indolizinderivaten
EP0288048B1 (de) Benzo- und Thieno-3,4-dihydro-pyridinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD202433A5 (de) Verfahren zur herstellung von amidobenzamiden
DE69004702T2 (de) Aminoalkoxyphenyl-Derivate, Verfahren zu ihrer Herstellung und diese Derivate enhaltende Zusammensetzungen.
DE69028355T2 (de) 4,5-Dihydro-6H-imidazo[4,5,1-ij]chinolin-6-on-6-oxim-O-sulfonsäurederivate
DE3439450A1 (de) 1,2,4-triazolo-carbamate und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
CH618439A5 (xx)
DE69022442T2 (de) Aminoalkoxyphenyl-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Zusammensetzungen.
DE2427272C3 (de) 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum
DE2404050A1 (de) Neue heterocyclische vrbindungen und verfahren zu deren herstellung
DE3134945A1 (de) Substituierte 2-amino-3,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
DE3650311T2 (de) Verwendung von Quinazolinen zur Herstellung eines Arzneimittels zur Behandlung und Vorbeugung von Arrhythmie.
EP0037471B1 (de) 1-Aroyl-2-phenylamino-2-imidazoline, ihre Herstellung und diese enthaltende Arzneimittel
DE1929921A1 (de) Neue 1-Alyl-1,2,5,6-tetrahydro-3-pyridylmethyl-carbonsaeureester sowie deren Saeureadditionssalze und quaternaere Ammoniumverbindungen
AT299202B (de) Verfahren zur Herstellung von neuen substituierten Isochinolinen und von deren Säureadditionssalzen
EP0266563B1 (de) Verwendung von 1-Benzyl-amino-alkyl-pyrrolidinonen als Antidepressiva

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee